Brief: Senti Biosciences Secures Additional Funding From Leaps By Bayer
24/05/2022 13:42
May 24 (Reuters) - Senti Biosciences Inc:
* SENTI BIOSCIENCES-ADDITIONAL FUNDING BY LEAPS BY BAYER, IN
FORM
OF NOTE SUBSCRIPTION AGREEMENT FOR UNSECURED, CONVERTIBLE
PROMISSORY NOTE OF $5.2 MILLION
Source text for Eikon: ID:nGNX7k1Jv8
Further company coverage: DYNS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Senti Biosciences Holdings
See all newsBrief: Senti Biosciences Says Offering 15.97 Million Shares Of Common Stock For Resale By Selling Securityholder
Senti Biosciences Q1 net loss narrows on cost reduction
Brief: Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy
Brief: Senti Biosciences Announces Holding Company Reorganization Effective By April 16, 2026 - SEC Filing
Senti Biosciences Q4 revenue misses analyst estimates